NCT00004436View on ClinicalTrials.gov

Randomized Study of Hormonal Regulation of Infantile Hemangioma

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 1993

Study Completion Date

June 30, 2000

Conditions
Hemangioma
Interventions
DRUG

leuprolide

DRUG

prednisone

All Listed Sponsors
collaborator

Boston Children's Hospital

OTHER

lead

FDA Office of Orphan Products Development

FED

NCT00004436 - Randomized Study of Hormonal Regulation of Infantile Hemangioma | Biotech Hunter | Biotech Hunter